Navigation Links
Insulet Awarded National Accreditation for Excellence by Community Health Accreditation Program
Date:9/27/2007

BEDFORD, Mass., Sept. 27 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the maker of the OmniPod(R) Insulin Management System, today announced that it has been awarded a home medical equipment accreditation from the Community Health Accreditation Program (CHAP) for achieving the organization's Standards of Excellence. CHAP is an independent, non-profit national accrediting body that is a leader in improving the quality of home and community-based health care organizations in the United States.

The OmniPod System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and virtually pain-free automated insertion. The System consists of the compact, lightweight OmniPod, which is worn discreetly beneath clothing and delivers insulin based on instructions from its wireless companion, the easy-to-use, handheld Personal Diabetes Manager (PDM). The PDM contains a fully integrated FreeStyle(R) blood glucose meter and is very similar in materials, construction and appearance to a personal digital assistant. The System is available in the eastern and mid-western U.S. and on the U.S. west coast

"We're honored to receive this recognition from CHAP and believe it demonstrates Insulet's commitment to providing a high-quality device with outstanding support services to our customers," said Duane DeSisto, President and Chief Executive Officer of Insulet. "Increasingly, insurance providers are requiring independent, third party validation of a product's quality standards in order to approve it for reimbursement. We expect that Insulet's CHAP accreditation will enable more people with insulin-dependent diabetes to gain access to OmniPod."

CHAP accreditation publicly certifies that an organization has voluntarily met the highest standards of excellence for home and community-based health care. Its Standards of Excellence are driven by considerations of quality, management, client outcomes, adequate resources, and long-term viability.

In 2006, CHAP was granted regulatory authorization by the Centers for Medicare and Medicaid Services to survey organizations providing home medical equipment to determine whether they meet the Medicare Conditions of Participation.

About Insulet Corporation

Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford, MA.

Media Contacts:

Paul Kidwell, Lazar Partners for Insulet Corporation, Tel. +1-617-296-3854 or +1-617-680-1088

E-mail: pkidwell@lazarpartners.com

Mark Sahl, Lazar Partners for Insulet Corporation, Tel. +1-646-871-8485 or +1-609-992-5205

E-mail: msahl@lazarpartners.com


'/>"/>
SOURCE Insulet Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
2. Scientists Awarded Appropriately For Contribution Towards Medical Research
3. International community warns India on HIV situation
4. Mexico and US border attain a new outlook due to BiNational Sustainability Laboratory
5. National Lung Study in the process
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. Key step forward on International Health Rules
8. ICMR along with other International Research organisation with drug development for Neglected Diseases
9. International Osteoporosis Research Centre To Be Started In India.
10. Hepatitis B Vaccine To Be Included In National Immunization Programme
11. Indian hospitals require International Accreditation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... February 12, 2016 , ... ... (WaaS), today announced the integration of Clarity Intelligence Platform (CIP) into Cielo®, a ... offer real-time business intelligence (BI) to their small and medium business (SMB) clients. ...
(Date:2/12/2016)... ... February 12, 2016 , ... The Jones Agency, a family ... eastern Texas, is launching a cooperative charity drive with the Tarrant Area Food Bank ... than 50,000 individuals and families in need, the Tarrant County Food Bank offers hope ...
(Date:2/12/2016)... ... 12, 2016 , ... Donor Network West, the organ procurement organization that heals ... with San Ramon Regional Medical Center. Under the collaboration, the first of its kind, ... accommodate a more certain time frame for donor families for the recovery of organs. ...
(Date:2/12/2016)... NY (PRWEB) , ... February 12, 2016 , ... ... of “Revolutionizing Cancer Care.” , The print component of “Revolutionizing Cancer ... Dallas, Pittsburgh/Cleveland, New York, Washington DC/Baltimore, and Seattle, with a circulation of approximately ...
(Date:2/12/2016)... ... February 12, 2016 , ... US Sport Camps is pleased to ... Club, located in Norwalk, serves as the host site and directing the camps is ... “We have had successful camps in recent years around Des Moines and are fortunate ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... , Feb. 12, 2016  Eli Lilly and Company (NYSE: ... decided the Alimta® (pemetrexed disodium) vitamin regimen patent would not ... UK, France , Italy ... dilute the product only with dextrose solution.  ... the UK Court of Appeal held that Lilly,s patent would ...
(Date:2/12/2016)... BUFORD, Ga. , Feb. 12 2016  OMS ... office-based dental and medical practitioners, announced today the recent ... website offers visitors a variety of features that enhance ... purchase oral surgery supplies. --> ... Supply is a fairly new company that started in ...
(Date:2/12/2016)... 12, 2016  Apellis Pharmaceuticals, Inc., today ... million Series D preferred stock financing, co-led ... Capital Group and venBio Global Strategic Fund, ... IB Investment, and Epidarex Capital. The proceeds of ... advance clinical trials in the Company,s ongoing ...
Breaking Medicine Technology: